A clinical study on the role of psychosomatic therapy in evaluation and treatment of patients with chronic obstructive pulmonary disease complicated with anxiety-depression disorder.

This study aimed to evaluate the effect of psychotic therapy on patients with chronic obstructive pulmonary disease (COPD) complicated with anxiety-depression disorder by Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), COPD Assessment Test (CAT) and modified British Medical research Council (mMRC). Thirty-five patients with COPD were evaluated by pulmonary physicians with CAT and mMRC. They were further evaluated with HAMD and HAMA by psychologists and diagnosed and grouped into group B and D according to the Global initiative for chronic Obstructive Lung Disease (GOLD) version 2014. Patients were given psychotic therapy and followed up for at least 1 month. Comparison and analysis were performed with clinical data before and after treatment. Fourteen patients were subscribed into B group, while 21 patients were subscribed into D group, accounting for 40% and 60% respectively. After psychotic therapy, the HAMA and MAMD score of patients in both groups improved significantly (P<0.05). The CAT and Mmrc score of 8 patients in B group improved as A, while 10 patients in D group improved as B. The longest follow-up was 12 months. Symptoms were significantly alleviated after combined respiratory and psychotic therapy. COPD complicated with anxiety-depression is of high prevalence. The psychosomatic problems usually aggravate respiratory symptoms. Make better use of the evaluation methods such as HAMA, HAMA, CAT, mMRC may facilitate the treatment for patients.